Compare LAZ & EXPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LAZ | EXPO |
|---|---|---|
| Founded | 1848 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Professional Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.4B |
| IPO Year | 2004 | 1996 |
| Metric | LAZ | EXPO |
|---|---|---|
| Price | $41.41 | $66.19 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $54.63 | ★ $88.00 |
| AVG Volume (30 Days) | ★ 1.5M | 425.4K |
| Earning Date | 04-24-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.82% | 1.86% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.17 | 2.07 |
| Revenue | ★ $3,186,466,000.00 | $582,014,000.00 |
| Revenue This Year | $15.20 | $12.75 |
| Revenue Next Year | $12.89 | $8.50 |
| P/E Ratio | ★ $19.10 | $32.11 |
| Revenue Growth | 1.48 | ★ 4.21 |
| 52 Week Low | $31.97 | $63.25 |
| 52 Week High | $58.75 | $83.92 |
| Indicator | LAZ | EXPO |
|---|---|---|
| Relative Strength Index (RSI) | 43.11 | 45.42 |
| Support Level | $38.67 | $64.55 |
| Resistance Level | $52.41 | $73.91 |
| Average True Range (ATR) | 1.61 | 2.17 |
| MACD | 0.56 | 0.11 |
| Stochastic Oscillator | 59.98 | 54.67 |
Lazard Inc is a financial advisory and asset management firm with operations in North and South America, Europe, the Middle East, Asia, and Australia. Lazard provides advice on mergers and acquisitions, capital markets and capital solutions, restructuring and liability management, geopolitics, and other strategic matters, as well as asset management and investment solutions to institutions, corporations, governments, partnerships, family offices, and high net worth individuals. Geographically, the company earns key revenue in the Americas, EMEA then Asia-Pacific.
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.